Heme Protein-induced Chronic Renal Inflammation: Suppressive Effect of Induced Heme Oxygenase-1
Overview
Authors
Affiliations
Background: Heme oxygenase (HO) is the rate-limiting enzyme in the degradation of heme; its inducible isozyme, HO-1, protects against acute heme protein-induced nephrotoxicity and other forms of acute tissue injury. This study examines the induction of HO-1 in the kidney chronically inflamed by heme proteins and the functional significance of such an induction of HO-1.
Methods: Studies were undertaken in a patient with chronic tubulointerstitial disease in the setting of paroxysmal nocturnal hemoglobinuria (PNH), in a rat model of chronic tubulointerstitial nephropathy caused by repetitive exposure to heme proteins, and in genetically engineered mice deficient in HO-1 (HO-1 -/-) in which hemoglobin was repetitively administered.
Results: The kidney in PNH evinces robust induction of HO-1 in renal tubules in the setting of chronic inflammation. The heme protein-enriched urine from this patient, but not urine from a healthy control subject, induced expression of HO-1 in renal tubular epithelial cells (LLC-PK1 cells). A similar induction of HO-1 and related findings are recapitulated in a rat model of chronic inflammation induced by repetitive exposure to heme proteins. Additionally, in the rat, the administration of heme proteins induces monocyte chemoattractant protein (MCP-1). The functional significance of HO-1 so induced was uncovered in the HO-1 knockout mouse: Repeated administration of hemoglobin to HO-1 +/+ and HO-1 -/- mice led to intense interstitial cellular inflammation in HO-1 -/- mice accompanied by striking up-regulation of MCP-1 and activation of one of its stimulators, nuclear factor-kappaB (NF-kappaB). These findings were not observed in similarly treated HO-1 +/+ mice or in vehicle-treated HO-1 -/- and HO-1 +/+ mice.
Conclusion: We conclude that up-regulation of HO-1 occurs in the kidney in humans and rats repetitively exposed to heme proteins. Such up-regulation represents an anti-inflammatory response since the genetic deficiency of HO-1 markedly increases activation of NF-kappaB, MCP-1 expression, and tubulointerstitial cellular inflammation.
Soladogun A, Zhang L Antioxidants (Basel). 2025; 13(12.
PMID: 39765770 PMC: 11672823. DOI: 10.3390/antiox13121441.
Kong W, Zhou W, He Z, Zhang X, Li S, Zhong R Front Bioeng Biotechnol. 2023; 11:1151975.
PMID: 36911194 PMC: 9995943. DOI: 10.3389/fbioe.2023.1151975.
Heme Proteins and Kidney Injury: Beyond Rhabdomyolysis.
Nath K, Singh R, Croatt A, Adams C Kidney360. 2022; 3(11):1969-1979.
PMID: 36514409 PMC: 9717624. DOI: 10.34067/KID.0005442022.
Genome-wide meta-analysis identifies new candidate genes for sickle cell disease nephropathy.
Garrett M, Soldano K, Erwin K, Zhang Y, Gordeuk V, Gladwin M Blood Adv. 2022; 7(17):4782-4793.
PMID: 36399516 PMC: 10469559. DOI: 10.1182/bloodadvances.2022007451.
Identification of Cytoprotective Small-Molecule Inducers of Heme-Oxygenase-1.
Ghajar-Rahimi G, Traylor A, Mathew B, Bostwick J, Nebane N, Zmijewska A Antioxidants (Basel). 2022; 11(10).
PMID: 36290611 PMC: 9598442. DOI: 10.3390/antiox11101888.